These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 4102807)

  • 41. The use of IgM tests for analysis of the causes of measles vaccine failures: experience gained in an epidemic in Hungary in 1980 and 1981.
    Nagy G; Kósa S; Takátsy S; Koller M
    J Med Virol; 1984; 13(1):93-103. PubMed ID: 6693863
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 43. Duration of immunity following immunization with live measles vaccine: 15 years of observation in Zhejiang Province, China.
    Dai B; Chen ZH; Liu QC; Wu T; Guo CY; Wang XZ; Fang HH; Xiang YZ
    Bull World Health Organ; 1991; 69(4):415-23. PubMed ID: 1934235
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunity to measles in children vaccinated before and after 1 year of age.
    Reynolds DW; Start A
    Am J Dis Child; 1972 Dec; 124(6):848-50. PubMed ID: 4639220
    [No Abstract]   [Full Text] [Related]  

  • 45. Measles antibody in previously immunized children. The need for revaccination.
    Linnemann CC; Dine MS; Bloom JE; Schiff GM
    Am J Dis Child; 1972 Jul; 124(1):53-7. PubMed ID: 5033750
    [No Abstract]   [Full Text] [Related]  

  • 46. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The epidemiology and nature of measles in Nairobi before the impact of measles immunization.
    Hayden RJ
    East Afr Med J; 1974 Feb; 51(2):199-205. PubMed ID: 4837256
    [No Abstract]   [Full Text] [Related]  

  • 48. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.
    Edmonson MB; Addiss DG; McPherson JT; Berg JL; Circo SR; Davis JP
    JAMA; 1990 May; 263(18):2467-71. PubMed ID: 2278542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 50. [Immunization against measles].
    Thomssen R
    Monatsschr Kinderheilkd (1902); 1970 Sep; 118(9):547-50. PubMed ID: 4107231
    [No Abstract]   [Full Text] [Related]  

  • 51. Measles vaccine effectiveness in central Australian aboriginal children vaccinated at or after eight months of age.
    Patel M; Lush D
    Aust N Z J Public Health; 1998 Oct; 22(6):729-30. PubMed ID: 9848973
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Atypical measles. Severe illness in recipients of killed measles virus vaccine upon exposure to natural infection.
    Brodsky AL
    JAMA; 1972 Dec; 222(11):1415-6. PubMed ID: 4678322
    [No Abstract]   [Full Text] [Related]  

  • 53. [Materials on the serologic study of children inoculated with live measles vaccine].
    Kaplan AS; Zubov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Dec; (12):64-70. PubMed ID: 602545
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles immune globulin. Proposed standard dose given with liver attenuated measles virus vaccine.
    Warren RJ; Nader PR; Levine RH
    JAMA; 1968 Jan; 203(3):186-8. PubMed ID: 4169348
    [No Abstract]   [Full Text] [Related]  

  • 55. Serological survey of measles in Yemen in 1985.
    Strauss J; Dobahi SS; Danes L; Kopecký K; Svandová E
    J Hyg Epidemiol Microbiol Immunol; 1989; 33(1):71-4. PubMed ID: 2723425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 57. [Measles outbreaks in the Bern canton].
    Maurer AM; Mühlemann K
    Schweiz Med Wochenschr; 1998 Feb; 128(9):317-22. PubMed ID: 9544458
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The impact of immunization against measles on epidemiology of measles in Poland].
    Janaszek W
    Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Measles vaccination. Serologic response and persistence of antibody titer by age at vaccination.
    Biberi-Moroeanu S; Munţiu A; Tiţeica M
    Arch Roum Pathol Exp Microbiol; 1982; 41(4):347-55. PubMed ID: 7171306
    [No Abstract]   [Full Text] [Related]  

  • 60. Measles prevention.
    Centers for Disease Control (CDC)
    MMWR Suppl; 1989 Dec; 38(9):1-18. PubMed ID: 2513473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.